Nigerian Hospital Achieves Milestone with 50 Robotic Prostate Surgeries

LAGOS, NIGERIA — Surgeons at Kelina Hospital, a private healthcare facility, have completed over 50 minimally invasive robotic operations to remove cancerous prostates within a single year, recording zero blood transfusions since June. Announcing the achievement at a press briefing in Lagos, Dr. Celsus Undie, President of Kelina Hospital and consultant urological surgeon, highlighted that integrating advanced robotic surgery in nigeria has enabled weekly robotic radical prostatectomies, with over half of patients discharged within 24 hours of surgery.
The medical program is managed entirely by resident Nigerian surgeons. Following the country’s first robotic radical nephrectomy in 2025, the facility has crossed more than 7,000 surgical operations overall.
Program Metrics and Robotic Surgery in Nigeria
Data disclosed by hospital executives outlines clinical outcomes and national prostate cancer epidemiology:
| Health & Clinical Indicators | National Metrics & Program Deliverables |
| Robotic Surgery Milestone |
50+ robotic radical prostatectomies completed within 12 months |
| Post-Operative Recovery |
>50% of patients discharged within 24 hours post-surgery |
| Prostate Cancer Burden |
24,396 new annual cases and 15,176 deaths reported nationally |
| Transfusion Protocol |
Zero blood transfusions required for robotic cases since June |
Technical Advantages of Robotic Surgery in Nigeria
To improve surgical precision and minimize operative trauma, surgical teams utilize advanced console-assisted robotic systems for complex robotic surgery in nigeria:
-
3D Magnified Visualization: Operating through small keyhole incisions using 3D high-definition vision consoles for precise anatomical dissection.
-
Functional Preservation: Enhancing surgical accuracy near nerve bundles to better preserve urinary control and erectile function.
-
Reduced Recovery Time: Lowering post-operative pain and blood loss to accelerate patient discharge timelines.
Early Screening, Cost Barriers, and Comprehensive Care
Prostate cancer remains the most diagnosed malignancy among Nigerian men, claiming approximately 26 lives every day. While the availability of robotic technology offers advanced domestic treatment options, public health experts emphasize that late clinical presentation remains the primary obstacle to lowering mortality. Most patients present only when the disease has metastasized beyond the prostate, rendering curative surgical intervention ineffective.
In addition, out-of-pocket payment models and high equipment consumables costs restrict access to high-tech private procedures. Achieving broader clinical impact requires expanding routine Prostate-Specific Antigen (PSA) blood testing, raising public awareness among men over 40, and strengthening regional pathology, radiotherapy, and hormonal therapy infrastructure across all geopolitical zones.
Why It Matters: While local robotic surgery capabilities expand advanced clinical choices, routine screening remains critical to detecting prostate cancer early enough for surgical cure.
Source:News Agency of Nigeria (NAN) Report, October 12, 2026.



